SFU
ALNY icon

Stonehage Fleming (UK)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Stonehage Fleming (UK)’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-308
Closed -$30K – 196
2014
Q4 		$30K Sell
308
-128
-29% -$11.9K 0.01% 216
2014
Q3 		$34K Sell
436
-26
-6% -$1.68K 0.02% 204
2014
Q2 		$29K Sell
462
-965
-68% -$57.4K 0.01% 214
2014
Q1 		$96K Buy
1,427
+236
+20% +$18.3K 0.04% 178
2013
Q4 		$77K Buy
+1,191
New +$71K 0.03% 179

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return